Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Other material
confidence 75%
filed 2026-07-07
Item 8.01
The disclosure announces a 1:200 reverse stock split approved by the board and effective July 12, 2026. While reverse stock splits are capital structure events that affect share count and pricing, they do not fit neatly into the specific taxonomy categories (not M&A, not a debt/equity issuance in the traditional sense, not a dividend, not a delisting notice). The event is material to investors as it materially alters the share structure and trading mechanics, but the domain is financial/capital structure rather than a named event type, warranting classification as other_material.
View raw filing on EDGAR →
6-K
Other material
confidence 72%
filed 2026-07-06
EX-99.1
Sun Life issued a cautionary news release regarding an unsolicited mini-tender offer by Ocehan LLC at a 24.95%–24.38% discount to recent market prices. While mini-tender offers are designed to avoid standard disclosure requirements and the SEC has flagged them as potentially deceptive, this disclosure does not fit neatly into the taxonomy: it is not a shareholder vote result, delisting risk, material litigation, or other named event type. The company is warning shareholders of a third-party offer, which is a material governance/shareholder-protection disclosure that would affect investor assessment, but the event itself (the unsolicited offer) is not a discrete corporate action by Sun Life. Classified as `other_material` because the domain is governance-adjacent but the specific nature—a cautionary disclosure about a third-party bid—does not match any defined category.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-07-06
Item 1.01
FortuneX Acquisition Corp entered into Amendment No. 1 to its Underwriting Agreement on July 1, 2026, revising terms related to its initial public offering, including provisions on Firm Units, Option Units, deferred underwriting discount, private placement units, and trust account acknowledgements. While this is a material definitive agreement under Item 1.01, it does not fit cleanly into the M&A activity category (which typically covers acquisitions, dispositions, mergers, or changes of control of the registrant itself) nor any other specific event type; it is a capital-raising and IPO-related amendment that would materially affect investors' understanding of the offering structure and terms.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-07-02
Item 7.01
This Item 7.01 disclosure consists of a shareholder letter and FAQs providing operational and performance updates on Blue Owl Credit Income Corp., including portfolio performance metrics, tender offer results, capital inflows, and liquidity position. While the letter addresses material business matters (tender demand, shareholder retention, portfolio quality, and liquidity), the disclosure does not fit neatly into a specific event taxonomy category—it is neither a discrete governance action, financial obligation, operational milestone, nor legal/regulatory event, but rather a comprehensive investor communication. The domain is clearly financial/operational, but the nature is primarily informational rather than a triggering event, making `other_material` the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-07-02
Item 8.01
This disclosure reports the consummation of Alpex Acquisition Corporation's initial public offering on June 26, 2026, raising $115 million in gross proceeds from the sale of 11.5 million units (including full exercise of the underwriter's over-allotment option) at $10.00 per unit, plus a concurrent private placement of 187,500 units to the sponsor for $1.875 million. While IPO completion is a material capital-raising event affecting the registrant's financial position and ability to pursue a business combination, it does not fit neatly into the standard 8-K taxonomy categories (which typically cover earnings releases, M&A activity, debt issuance, or other specific financial/operational events). The event is clearly material to investors but is best classified as a capital formation milestone that does not match a named category.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-07-01
Item 3.03
Item 3.03 discloses a material modification to security holders' rights by incorporating Item 2.01 content. The specific nature of the modification cannot be determined without access to the referenced Explanatory Note and Item 2.01 content, but the incorporation by reference indicates a material event affecting security holders.
View raw filing on EDGAR →
6-K
Other material
confidence 72%
filed 2026-07-01
EX-99.1
The exhibit announces an ADS ratio change (1 ADS representing 60 Class A shares, effective as a 1-for-30 reverse ADS split) becoming effective July 6, 2026. This is a material capital structure event affecting all ADS holders' share counts and trading price, but it does not fit neatly into the taxonomy's specific event types—it is neither a dilutive issuance, dividend distribution, nor a governance action requiring shareholder approval. The event is clearly material to investors (affects trading mechanics and share count) but belongs in the financial domain without a precise category match.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-30
Item 8.01
This disclosure describes the consummation of Gores Holdings XI's initial public offering on June 24, 2026, raising $358.8 million in gross proceeds from the sale of 35.88 million units (including over-allotment), plus a concurrent private placement of 225,000 Class A shares to the sponsor for $2.25 million. While the IPO itself is a capital-raising event that would normally be classified as a dilutive_issuance, the filing is structured as Item 8.01 (Other Events) rather than Item 3.02, and the disclosure emphasizes the consummation of the IPO and trust account mechanics rather than the equity issuance per se. The event is material to investors as it establishes the company's capitalization and trust account structure, but the specific event type is ambiguous given the Item placement and the emphasis on the IPO completion rather than the equity issuance mechanics alone.
View raw filing on EDGAR →
6-K
Other material
confidence 72%
filed 2026-06-29
The 6-K discloses that Shinhan Financial Group is "currently reviewing various measures" including a potential acquisition of Lotte Insurance in response to media reports. While no decision has been finalized, the disclosure of active review of a material acquisition would affect a reasonable investor's assessment of the registrant's strategic direction and capital allocation. The matter does not fit cleanly into `ma_activity` (which typically covers completed, entered, or terminated transactions) because the acquisition remains under review with no finalized decision, but the materiality and strategic significance warrant classification as a material event rather than routine administrative disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-29
Item 8.01
This disclosure announces the completion of a SPAC's IPO, full exercise of the underwriters' over-allotment option (bringing total units to 23 million and gross proceeds to $230 million), and the commencement of separate trading of Class A Ordinary Shares and Warrants on the NYSE. While the IPO itself is a capital-raising event material to investors, it does not fit neatly into the standard taxonomy categories (not earnings_release, debt_issuance, dilutive_issuance, or dividend_distribution). The event is clearly financial and material, but the taxonomy lacks a dedicated SPAC IPO or capital-raising category, making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-29
Item 8.01
This Item 8.01 disclosure reports the Company's Net Asset Value (NAV) per share as of May 31, 2026, and provides a status update on its ongoing public and private offerings. While NAV reporting is routine for closed-end funds and investment companies, the disclosure includes material information about the Company's aggregate net asset value ($732.7 million), investment portfolio fair value ($1.06 billion), and the progress of its $2.0 billion continuous offering ($666.1 million raised to date). The event does not fit neatly into a specific category—it is neither a financial result (earnings_release), a capital transaction (debt_issuance, dilutive_issuance), nor a governance or operational event. The domain is clearly financial/informational, but the specific type is administrative NAV reporting combined with offering status, making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-26
Item 3.03
ProAssurance disclosed a material modification to the rights of security holders by cross-reference to Items 2.01, 3.01, 5.01, and 5.03, relating to the merger completion, delisting, change of control, and governance amendments.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-26
Item 7.01
GameStop disclosed forward-looking guidance for fiscal year 2026 Adjusted EBITDA in excess of $600 million, representing a 74% increase from prior-year Adjusted EBITDA of $345.4 million. While this is a forward-looking financial projection rather than a historical earnings release, it is material guidance that would affect investor assessment of the company's financial trajectory. The disclosure does not fit cleanly into "earnings_release" (which typically covers actual historical results) but represents a significant forward-looking financial statement that a reasonable investor would consider material to their investment decision.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-25
This 8-K discloses the consummation of Aeon Acquisition I Corp.'s IPO on June 4, 2026, generating $125 million in gross proceeds plus $18.75 million from the over-allotment option exercise, with $143.75 million deposited in trust. While the filing includes an audited balance sheet and a going-concern explanatory paragraph in the auditor's report, the primary disclosed event is the IPO completion itself. The going-concern language is standard for blank-check companies and does not constitute a material going-concern disclosure requiring separate classification. The IPO is a material capital-raising event but does not fit neatly into the taxonomy's specific categories (it is neither a debt issuance, dilutive equity issuance, nor a traditional earnings release), warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-24
Item 8.01
The filing discloses the consummation of Yorkville International Capital Corp.'s IPO on June 17, 2026, generating $230 million in gross proceeds from the sale of 23 million units at $10.00 per unit, plus a concurrent private placement of 6.3 million warrants for $6.3 million. While this is clearly a material capital-raising event affecting a reasonable investor's assessment of the registrant, it does not fit neatly into the standard 8-K taxonomy. The event is neither a traditional earnings release, M&A activity, debt issuance, nor dilutive equity issuance in the conventional sense (the IPO itself is the primary capital event, not a secondary offering). The company is a SPAC with no operating business, making traditional financial event categories inapplicable. The domain is clearly financial/capital-related, but no specific category captures an IPO consummation disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-24
Item 1.02
Item 1.02 discloses termination of a material definitive agreement and incorporates Item 1.01 by reference. Without visibility into the specific agreement terminated and circumstances, the precise nature of this event cannot be determined, though the explicit 'Material Definitive Agreement' language indicates materiality.
View raw filing on EDGAR →
6-K
Other material
confidence 75%
filed 2026-06-23
EX-99.1
The press release announces a plan to implement a 1-for-25 reverse ADS split (changing the ADS ratio from 1 ADS per 18 ordinary shares to 1 ADS per 450 ordinary shares), effective June 25, 2026. While this is a capital structure event affecting the trading mechanics of the company's ADSs on NASDAQ, it does not fit neatly into the standard taxonomy categories. It is not a dilutive issuance (no new securities issued), not a dividend distribution, and not a governance matter in the traditional sense. The event is material to investors as it affects the trading price and share structure, but the specific mechanism—a reverse ADS split—does not align with any named event type, warranting classification as `other_material`.
View raw filing on EDGAR →
6-K
Other material
confidence 65%
filed 2026-06-23
The 6-K discloses two related transactions by Chairman Choo Chee Kong: (1) an offer to acquire up to 200,000 Company shares from independent shareholders via private purchase agreement, and (2) a S$300,000 investment by his wholly-owned EP Capital Inc. into LongevityBank (a Company subsidiary), increasing EP Capital's stake from 6.4% to 12.0%. While these transactions involve significant capital deployment and potential changes to shareholding structure and subsidiary ownership, they do not fit neatly into standard event categories—they are neither a formal M&A transaction (no merger or acquisition of the Company itself), nor a simple insider share purchase, nor a capital raise by the Company. The disclosure is material because it signals insider confidence and capital commitment, but the event's nature—insider accumulation and subsidiary investment—is ambiguous enough to warrant the catch-all category.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-22
Item 1.02
The filing discloses termination of a material definitive agreement referenced in Item 1.02, with cross-references to Item 5.02, but substantive details regarding the agreement's nature, termination circumstances, and financial impact are not provided in the Item classifications.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-22
The filing discloses expiration of 9.6 million cash warrants and cancellation of 7.1 million pre-funded warrants, eliminating 16.7 million shares of dilution overhang. While warrant expiration reduces shareholder dilution, it does not fit neatly into the taxonomy: it is neither a dilutive issuance (which involves new equity creation) nor a standard capital event. The disclosure is material to investors assessing equity structure and ownership dilution, but the specific event type—warrant expiration reducing dilution—lacks a dedicated category.
View raw filing on EDGAR →
6-K
Other material
confidence 72%
filed 2026-06-22
The filing discloses S&P Global Ratings' upgrade of Bladex's long-term issuer credit rating from 'BBB' to 'BBB+' and affirmation of short-term rating at 'A-2', with stable outlook. While this is a material credit-rating event that would affect investor assessment of the registrant's creditworthiness and financial standing, it does not fit neatly into the standard 8-K taxonomy (no dedicated category for credit-rating upgrades). The domain is clearly financial, but the specific event type is not a named category, making `other_material` the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 7.01
Camden National Corporation furnished an investor presentation under Item 7.01 (Regulation FD Disclosure) for use in upcoming investor meetings. The presentation contains comprehensive financial and operational information including balance sheet metrics ($7.0B assets, $5.6B deposits), strategic objectives, capital management, and forward-looking statements. While Item 7.01 disclosures are typically routine, this presentation is material to investors as it provides substantive updates on the company's financial position, strategic initiatives, and performance metrics that would affect investment decisions, particularly given the company's recent Northway acquisition and ongoing capital management strategy.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Item 7.01
The filing discloses estimated catastrophe losses of $289 million ($228 million after-tax) for May 2026 and cumulative losses of $1.16 billion for April-May, along with monthly policy-in-force metrics. While catastrophe loss disclosures are routine operational updates for insurance companies, the magnitude of losses ($1.16 billion over two months) and the explicit mention that this is a "monthly release" announcing "estimated catastrophe losses" suggests material financial impact. However, this does not fit cleanly into the standard 8-K taxonomy—it is neither a full earnings release (Item 2.02), a material impairment charge (Item 2.06), nor a covenant breach. The disclosure is furnished under Regulation FD (Item 7.01) as supplemental investor information rather than as a formal financial statement restatement or impairment charge.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Item 8.01
DTE Energy completed a $1 billion issuance of junior subordinated debentures due 2058. While this is a material debt financing event that would affect investor assessment of the company's capital structure and leverage, it does not fit cleanly into the more specific taxonomy categories (ma_activity, dilutive_issuance, or earnings_release). The disclosure is primarily administrative—reporting the completion of a registered debt offering—rather than a triggering event like a covenant breach or going-concern issue. Classified as other_material because the magnitude ($1B) and nature (long-term subordinated debt) are material to a reasonable investor, but the event itself is a routine capital markets transaction.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-18
Item 8.01
SR Bancorp announced a 20% increase in its quarterly cash dividend from $0.05 to $0.06 per share, declared by the Board on June 18, 2026. While dividend announcements are routine corporate actions, a 20% increase signals management confidence in earnings and financial strength and is material to shareholders evaluating total return. However, this does not fit cleanly into the standard 8-K taxonomy (no dedicated event type for dividend increases), so "other_material" is most appropriate.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-18
Item 8.01
The filing announces additional customer orders for RAD security products (three RIO 180 trailers and two RIO Mini units) from healthcare and construction clients expanding existing deployments. While this represents positive business development and revenue opportunity, it does not fit cleanly into standard 8-K event categories. The disclosure emphasizes "meaningful" recurring revenue contribution and customer expansion, which would be material to investors assessing growth prospects, but the announcement lacks the specificity of a formal earnings release or material contract disclosure that would typically trigger earnings_release or ma_activity classification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
The company disclosed a fundamental shift in business operations from vitamin supplements to oil and gas exploration, representing a material strategic pivot in the registrant's business direction and risk profile.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Item 7.01
TransCode posted a corporate presentation to its website on June 18, 2026, disclosing clinical trial progress (Phase 1a and Phase 2a data for TTX-MC138, Phase 3 status for Seviprotimut-L vaccine), pipeline details, and management/advisory board information. While the presentation contains material clinical and operational information relevant to investors, it does not fit neatly into the standard 8-K event categories (no earnings release, executive change, M&A, restatement, impairment, or other discrete triggering event). The disclosure is furnished under Item 7.01 (Regulation FD Disclosure) as a non-filed investor presentation, making it a material corporate communication that falls outside the more specific taxonomy.
View raw filing on EDGAR →
8-K
Other material
confidence 71%
filed 2026-06-18
Item 1.01
BrightView extended the maturity of its senior secured term loans from April 2029 to June 2033 (Amendment No. 11 to Credit Agreement) and its receivables financing facility from June 2027 to June 2029 (Sixth Amendment to Receivables Financing Agreement). These refinancings strengthen the company's balance sheet by extending its debt maturity profile and providing additional liquidity runway.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
The Company disclosed its net asset value per share of $29.18 as of May 31, 2026 (aggregate NAV of $1.589 billion) and reported that its ongoing private offering has raised $1.748 billion of a $5.0 billion target, providing investors with current valuation and offering progress metrics.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 5.03
Yorkville filed amended and restated memorandum and articles of association in connection with its IPO, implementing corporate governance amendments required for the company's transition to a publicly traded blank-check SPAC.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 3.03
FirstCash completed a reincorporation from Delaware to Texas on June 18, 2026, following stockholder approval at the June 9, 2026 Annual Meeting. The Company's governance shifted from Delaware law to Texas law with automatic 1:1 conversion of shares and new Texas Charter/Bylaws, though stockholders' economic rights remain substantially unchanged.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Item 8.01
Grace Therapeutics disclosed an update to its corporate presentation on June 18, 2026, which includes material regulatory and clinical information about GTx-104. The presentation details the FDA's Complete Response Letter (CRL) received in April 2026 citing CMC and manufacturing deficiencies (not clinical deficiencies), a scheduled Type A meeting with the FDA, and comprehensive Phase 3 STRIVE-ON trial data showing clinical and pharmacoeconomic benefits over oral nimodipine. While the CRL itself represents a regulatory setback, the disclosure centers on updating investors with the company's regulatory pathway forward and clinical evidence supporting GTx-104's potential. This does not fit neatly into the more specific categories (not a restatement, going concern, impairment, or litigation), but the regulatory status and clinical trial results are material to investor assessment of the company's prospects.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
AmperCap Acquisition Company disclosed the consummation of its IPO on June 4, 2026, raising $125 million in gross proceeds from 12.5 million units at $10.00 per unit, plus concurrent private placement proceeds of $5.125 million and subsequent over-allotment exercise proceeds of $18.375 million. While IPO disclosures are typically routine, this filing is material to investors as it establishes the company's capital structure, trust account mechanics ($126.25 million placed in trust), and the framework for a future business combination. The disclosure does not fit neatly into "earnings_release" (no financial results) or other specific event types, making "other_material" the most appropriate classification for this SPAC formation and capitalization event.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 7.01
Enanta announced advancement of zelicapavir into a registrational Phase 2b/3 clinical trial following a successful End-of-Phase 2 FDA meeting, plus initiation of a pediatric Phase 2b trial, both with topline data expected in 2027. This represents material clinical development progress for a lead program in a clinical-stage biotech company, but does not fit neatly into the standard 8-K event taxonomy (not an earnings release, executive change, M&A, impairment, or other discrete event type). The disclosure is furnished under Item 7.01 (Regulation FD Disclosure) and is clearly material to investors assessing the company's pipeline advancement and near-term catalysts.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 7.01
Graham Corporation disclosed slides for its 2026 Investor Day presentation posted to its investor relations website on June 18, 2026, furnished under Item 7.01 (Regulation FD Disclosure). The presentation includes forward-looking guidance on 3-year targets (8-10% incremental margin expansion, >14% organic revenue CAGR, selective M&A, and top-quartile enterprise ROIC through FY27-FY29), strategic initiatives, and detailed business segment performance. While Regulation FD disclosures are typically routine, this presentation contains material forward-looking financial targets and strategic guidance that would affect a reasonable investor's assessment of the company's growth trajectory and capital allocation plans, warranting classification as a material event that does not fit the more specific categories.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
Atmos Energy entered into an underwriting agreement on June 15, 2026 to issue $700 million in 4.750% Senior Notes due 2032 in a registered public offering, with expected net proceeds of approximately $693.9 million. While this is a material debt issuance that would affect a reasonable investor's assessment of the company's capital structure and financial position, it does not fit cleanly into the more specific event categories (it is not M&A activity, a restatement, auditor change, going concern, impairment, delisting risk, bankruptcy, covenant breach, cybersecurity incident, dilutive equity issuance, or litigation). The disclosure is a straightforward debt financing announcement properly classified as other material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
Broadcom announced the pricing, expiration, and results of cash tender offers for approximately $2.9 billion in outstanding debt securities, with an upsize of the consideration cap from $2.5 billion to $3.0 billion. While this is a material capital structure transaction affecting the company's debt profile, it does not fit neatly into the standard M&A taxonomy (ma_activity typically covers acquisitions, dispositions, mergers, or changes of control). The tender offer is a debt refinancing/repurchase activity that would materially affect investor assessment of the company's financial position and leverage, but lacks a dedicated 8-K event type.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
This disclosure reports the Company's Net Asset Value (NAV) per share as of May 31, 2026, across six classes of common shares and OP Units, calculated in accordance with board-approved valuation guidelines. For a non-traded REIT, NAV per share is a critical metric for investor valuation and redemption pricing, making this material to shareholders. However, it does not fit neatly into the more specific event categories (e.g., earnings_release, which typically involves P&L results rather than NAV-only disclosures), warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
This disclosure reports the Company's Net Asset Value (NAV) per share as of May 31, 2026, broken down by share class, along with detailed components of NAV and month-over-month comparison to April 30, 2026. For a non-traded REIT, NAV per share is a critical valuation metric that directly affects investor pricing and redemption decisions. While this is a routine monthly NAV disclosure typical of non-traded REITs, it is material to investors assessing the registrant's value and performance. The event does not fit neatly into more specific categories (not earnings, not an impairment, not a going-concern issue), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
NVIDIA completed a $24.5 billion debt offering across seven tranches of senior notes with maturities from 2028 to 2056. While this is a material financing event affecting the company's capital structure and liquidity, it does not fit cleanly into the standard 8-K taxonomy—it is neither a dilutive equity issuance (Item 3.02) nor a covenant breach or going-concern disclosure. The disclosure is routine debt issuance documentation filed under Item 8.01 (Other Events), making "other_material" the most appropriate classification for this significant but structurally standard debt capital raise.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-18
Item 1.01
Silvercrest entered into a Second Amendment to its credit agreement with City National Bank, extending the term loan maturity to June 18, 2029 and establishing a $5.0 million term loan commitment plus a $10.0 million revolving facility. This amendment creates a direct financial obligation affecting the company's capital structure and debt obligations.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-18
Item 1.01
Whirlpool entered into a First Supplemental Indenture on June 18, 2026, amending the indenture governing its 1.100% Notes due 2027 to accelerate the satisfaction and discharge timeline from one year to two years. This material amendment affects the company's debt obligations and refinancing flexibility.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-18
Item 8.01
The board of directors declared a quarterly distribution of $0.25 per share ($1.00 annualized) for American Healthcare REIT shareholders. This distribution declaration is material to investors as it affects shareholder returns and capital allocation expectations, though it does not fit the more specific 8-K event categories.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Item 8.01
BCB Bancorp's Board voted to suspend quarterly cash dividends on common and preferred stock and suspend its dividend reinvestment plan, citing the need for capital preservation during a "fulsome evaluation of the Bank's credit portfolios." The CEO explicitly states this decision is to preserve the Bank's "well-capitalized" position, signaling underlying credit or capital concerns. While dividend suspension is material to investors, it does not fit neatly into the more specific event categories (not a restatement, going-concern disclosure, covenant breach, or impairment charge), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Item 7.01
This Item 7.01 disclosure announces an updated investor presentation posted to the company's website on June 17, 2026. The presentation contains material forward-looking statements regarding the pending Canyon Creek acquisition, anticipated dividend increases from $1.35 to $1.50 per share post-close, a $1.0Bn Goldman Sachs ABS Warehouse Facility, and a $15Bn acquisition pipeline. While the presentation itself is furnished (not filed) under Regulation FD, the substantive disclosures—particularly the acquisition economics, financing arrangements, and dividend guidance—constitute material updates to investors about the company's strategic direction and financial outlook. This does not fit neatly into the more specific event categories (it is not an earnings release, M&A completion, or compensation arrangement), but the forward-looking guidance and acquisition-related disclosures are material to a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Item 8.01
Cadrenal announced plans to submit a Rare Pediatric Disease Designation (RPDD) request to the FDA for tecarfarin in Kawasaki disease, which if granted would make the company eligible for a Priority Review Voucher valued at $180–$205 million. The company also disclosed a dual-track portfolio strategy representing a material strategic and regulatory development affecting investor expectations around value creation and capital efficiency.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-18
Item 7.01
BiomX disclosed a strategic transition to a defense and security technology holding company and posted an updated investor presentation reflecting this repositioning. While Item 7.01 (Regulation FD Disclosure) is typically used for routine informational updates, the substance here—a completed "fundamental strategic transition" away from legacy clinical-stage biotech activities—is material to investors' understanding of the company's business model, portfolio, and strategy. The press release and presentation emphasize real deployments, customer relationships (Elbit Systems, Rafael), and a new operating framework (Detection-Analysis-Response), which would affect a reasonable investor's assessment. However, this does not fit neatly into the specific event-type taxonomy (not M&A, not an executive change, not a restatement or impairment), so "other_material" is most appropriate.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
The disclosure announces the commencement of separate trading of Class A Ordinary Shares and Warrants from Units following the Company's IPO completed on June 4, 2026. This is a routine post-IPO administrative event related to unit separation and listing mechanics. While it affects the trading structure of the Company's securities, it does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A activity, impairment, covenant breach, or other defined material events). The event is material to investors as it affects how the Company's securities trade, but it is primarily a procedural/administrative disclosure rather than a substantive business or financial event.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 5.03
The Company filed Amended and Restated Memorandum and Articles of Association effective June 17, 2026, in connection with the completion of its $250 million IPO. While the governing document amendment itself is administrative, the IPO context makes this structural formalization material to investors.
View raw filing on EDGAR →